<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8504048</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1710</journal-id>
<journal-id journal-id-type="nlm-ta">Bone</journal-id>
<journal-id journal-id-type="iso-abbrev">Bone</journal-id>
<journal-title-group>
<journal-title>Bone</journal-title>
</journal-title-group>
<issn pub-type="ppub">8756-3282</issn>
<issn pub-type="epub">1873-2763</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31121355</article-id>
<article-id pub-id-type="pmc">6615562</article-id>
<article-id pub-id-type="doi">10.1016/j.bone.2019.05.024</article-id>
<article-id pub-id-type="manuscript">NIHMS1531213</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Ca<sub>V</sub>1.2 L-type calcium channel regulates bone homeostasis in the middle and inner ear</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Chike</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oswald</surname>
<given-names>Aaron B.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fabella</surname>
<given-names>Brian A.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ren</surname>
<given-names>Yinshi</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodriguiz</surname>
<given-names>Ramona</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trainor</surname>
<given-names>George</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greenblatt</surname>
<given-names>Matthew B.</given-names>
</name>
<xref ref-type="aff" rid="A7">g</xref>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hilton</surname>
<given-names>Matthew J.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pitt</surname>
<given-names>Geoffrey S.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Cardiovascular Research Institute, Weill Cornell Medical College, 413 East 69<sup>th</sup> st. New York, New York, USA, 10021</aff>
<aff id="A2"><label>b</label>Howard Hughes Medical Institute and Laboratory of Sensory Neuroscience, The Rockefeller University, 1230 York Avenue, New York, New York, USA, 10065</aff>
<aff id="A3"><label>c</label>Department of Orthopaedic Surgery</aff>
<aff id="A4"><label>d</label>Department of Cell Biology, Duke University School of Medicine, 450 Research Drive, Durham, North Carolina, USA, 27710</aff>
<aff id="A5"><label>e</label>Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University School of Medicine, 308 Research Drive, Durham, North Carolina, USA, 27708</aff>
<aff id="A6"><label>f</label>Harrington Discovery Institute, Innovation Support Center, 2103 Cornell Road, Cleveland, Ohio, USA, 44106</aff>
<aff id="A7"><label>g</label>Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA, 10021</aff>
<aff id="A8"><label>h</label>Research Division, Hospital for Special Surgery, New York, NY, USA, 10021</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions</p>
<p id="P2">CC conceived and carried out experiments, analyzed data and wrote the paper. ABO and BAF carried out experiments and analyzed data. YR and RR carried out experiments and analyzed data. GT, MBG and MJH conceived of experiments. GSP conceived of experiments, analyzed data, and wrote the paper. All authors were involved in writing the paper and had final approval of the submitted version.</p>
</fn>
<corresp id="CR1"><label>*</label>To whom correspondence should be addressed. <email>chc2076@med.cornell.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P31">Conflicts of interest</p>
<p id="P32">All authors have nothing to disclose.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>125</volume>
<fpage>160</fpage>
<lpage>168</lpage>
<!--elocation-id from pubmed: 10.1016/j.bone.2019.05.024-->
<abstract id="ABS1">
<p id="P3">Bone remodeling of the auditory ossicles and the otic capsule is highly restricted and tightly controlled by the osteoprotegerin (OPG) / receptor activator of nuclear factor kappa-B ligand (RANKL) / receptor activator of nuclear factor kappa-B (RANK) system. In these bony structures, a pathological decrease in OPG expression stimulates osteoclast differentiation and excessive resorption followed by accrual of sclerotic bone, ultimately resulting in the development of otosclerosis, a leading cause of deafness in adults. Understanding the signaling pathways involved in maintaining OPG expression in the ear would shed light on the pathophysiology of otosclerosis and other ear bone-related diseases. We and others previously demonstrated that Ca<sup>2+</sup> signaling through the L-type Ca<sub>V</sub>1.2 Ca<sup>2+</sup> channel positively regulates OPG expression and secretion in long bone osteoblasts and their precursor cells <italic>in vitro</italic> and <italic>in vivo.</italic> Whether Ca<sub>V</sub>1.2 regulates OPG expression in ear bones has not been investigated. We drove expression of a gain-of-function Ca<sub>V</sub>1.2 mutant channel (Ca<sub>V</sub>1.2<sup>TS</sup>) using <italic>Col2a1-Cre,</italic> which we found to target osteochondral/osteoblast progenitors in the auditory ossicles and the otic capsule. <italic>Col2a1-Cre;Ca</italic><sub><italic>V</italic></sub><italic>1.2</italic><sup><italic>TS</italic></sup> mice displayed osteopetrosis of these bones shown by Î¼CT 3D reconstruction, histological analysis, and lack of bone sculpting, findings similar to phenotypes seen in mice with an osteoclast defect. Consistent with those observations, we found that <italic>Col2a1-Cre;Ca</italic><sub><italic>V</italic></sub><italic>1.2</italic><sup><italic>TS</italic></sup> mutant mice showed reduced osteoclasts in the otic capsule, upregulated mRNA expression of <italic>Opg</italic> and <italic>Opg/Rankl</italic> ratio, and increased mRNA expression of osteoblast differentiation marker genes in the otic capsule, suggesting both an anti-catabolic and anabolic effect of Ca<sub>V</sub>1.2<sup>TS</sup> mutant channel contributed to the observed morphological changes of the ear bones. Further, we found that <italic>Col2a1-Cre;Ca</italic><sub><italic>V</italic></sub><italic>1.2</italic><sup><italic>TS</italic></sup> mice experienced hearing loss and displayed defects of body balance in behavior tests, confirming that the Ca<sub>V</sub>1.2-dependent Ca<sup>2+</sup> influx affects bone structure in the ear and consequent hearing and vestibular functions. Together, these data support our hypothesis that Ca<sup>2+</sup> influx through Ca<sub>V</sub>1.2<sup>TS</sup> promotes OPG expression from osteoblasts, thereby affecting bone modeling/remodeling in the auditory ossicles and the otic capsule. These data provide insight into potential pathological mechanisms underlying perturbed OPG expression and otosclerosis.</p>
</abstract>
<kwd-group>
<kwd>Ca<sub>V</sub>1.2</kwd>
<kwd>Ca<sup>2+</sup> signaling</kwd>
<kwd>osteoprotegerin</kwd>
<kwd>otosclerosis</kwd>
<kwd>osteoclast</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>